key: cord-1014991-0kuinian
authors: Pegiou, Stavroula; Rentzeperi, Elpiniki; Koufakis, Theocharis; Metallidis, Symeon; Kotsa, Kalliopi
title: The role of sexual dimorphism in susceptibility to SARS-CoV-2 infection, disease severity, and mortality: facts, controversies and future perspectives
date: 2021-06-12
journal: Microbes Infect
DOI: 10.1016/j.micinf.2021.104850
sha: 26cfa4da2ef870065690cc581703936b53c6a38b
doc_id: 1014991
cord_uid: 0kuinian

Former studies have revealed intersex variability in immune response to infectious diseases, including Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological surveillance of the ongoing pandemic has demonstrated a male vulnerability to morbidity and mortality, despite similar infection rates between the two sexes. Divergence in the frequency of comorbidities between males and females, differences in hormonal profile, chromosomal composition and gender behavior have all been proposed as potential causative factors. Data deriving from the immunization process indirectly support the existence of a sex-specific response to SARS-CoV-2, since females apparently produce higher numbers of antibodies while simultaneously exhibiting higher rates of side effects, indicating a stronger immune reactivity to the vaccine’s elements. Interpreting intersex differences in immune response to SARS-CoV-2 could lead to a deeper understanding of the COVID-19 pathophysiology and enable healthcare professionals to conduct a more accurate patient risk assessment and better predict the clinical outcome of the disease. This narrative review aims to discuss the pathophysiological and behavioral basis of the disproportionate male morbidity and mortality observed in COVID-19, in the context of most research findings in the field.

obesity and diabetes, typically manifested at different frequencies between sexes in and membrane receptors, the latter most commonly acting as G protein-coupled 147 receptors (GPER). Upon their activation, ERα and ERβ target their respective 148 response elements in the deoxyribonucleic acid (DNA) sequence to promote various 149 epigenetic changes, whereas GPERs function via non-genomic signaling. 150

These receptors are present on the surface of several immune cell types such as 151

In this way, immune cells can be directly affected by the circulating estrogen levels, 153 responding in accordance to the type of receptors they express [22] . 154

For example, in T-lymphocytes, expression of Erα and Erβ and their relative ratio is 155 of crucial significance as it determines the cell's course of action, with the two 156 receptors often displaying antagonistic effects. Namely, Erβ signaling is required for 157 tissue growth factor-β differentiation of T regulatory (T reg ) cells, therefore promoting 158 immunosuppression, whereas Erα signaling leads to immune stimulation [23] . 159

However, estrogen signaling is not the only known mechanism promoting T reg cell 160 differentiation. More specifically, a study conducted in vitro showed that testosterone 161 can also lead to the generation of T reg cells from naive T-cells, suggesting an 162 alternative hormone-dependent pathway of immunosuppression in males [24] . 163

Apart from the individual properties of the estrogenic receptors, the level of 164 circulating estrogen also impacts the immune response, since estrogen signaling 165 functions in a dose-dependent manner. At low concentrations, estrogens may 166 stimulate the immune response, whereas at higher concentrations they exert an 167 immunosuppressive function, mimicking the action of glucocorticoids [25] . Estrogens 168 strengthen the immune response by augmenting antibody production through the 169 enhancement of the somatic hypermutation of immunoglobulins and by increasing the In this context, females may elicit stronger immune responses compared to their male 173 counterparts, possibly serving the purposes of the evolutionary process. Natural 174 selection may favor females with a more adequate immune system, since during 175 pregnancy and lactation a more intense production of antibodies is needed in order to 176 shield the fetus and -later on -the neonate against infectious diseases, acknowledging 177 that their only protection comes from maternal antibodies [28] . 178

In accordance to the above, one component of the female immune system that is 179 heavily influenced by E2, is antigen presentation and primarily the activity of 180 dendritic cells (DCs). At low doses of E2, DCs are upregulated during inflammation 181 and produce more interferon 1 and proinflammatory cytokines such as interleukin-8 182 conducted on mouse specimens that were infected with mouse-adapted SARS-CoV. 228

More specifically, it was found that even though gonadectomy did not alter the 229 clinical outcome in male mice, ovariectomy or treatment with estrogen antagonists 230 resulted in increased mortality in female specimens. Consequently, it can be strongly 231 asserted that the protective shield that females hold against SARS-CoV can be 232 attributed to the presence of higher circulating levels of estrogen. Another important 233 finding was that the survival difference was age dependent. Particularly in the young 234 and old age groups, the deviation of mortality rates between the two sexes was 235 insignificant, whereas in middle aged mice an extremely noticeable difference was 236 observed, with males presenting a remarkably higher mortality rate than females. 237

These differences can be once again explained by the protective action of estrogens, 238 which safeguard female mice in their middle-aged years, but gradually decline as the 239 animals' transition to perimenopause and menopause state [37]. 240

The above observations refer to mouse species, but several research data suggest a 241 common pattern in humans. In all age groups a male bias in mortality exists, however 242 this predominance is pronounced in the age group of 30 to 75 years [26] . This was 243 also supported by a study which concluded that young women In an animal model experiment, ACE2 knockout mice were compared with wild-type 279 mice after acid aspiration, a common cause of acute respiratory distress syndrome. 280

The results demonstrated that ACE2 knockout mice had diminished oxygenation and 281 exacerbated lung pathology, manifested by massive lung edema, increased 282 accumulation of inflammatory cells and hyaline membrane formation in comparison 283 with their wild-type counterparts [45] . . This is of great interest since it is known that in aged 462 individuals sex steroid hormone production is blunted [79] . Consequently, this 463 reduction may create a more homogenous hormonal environment, thus alleviating 464 possible differences encountered between sexes during their earlier life stages. One 465 more important finding of the same study is the fact that antibody production was 466 directly associated with hormone levels in a linear fashion in adult mice. More 467 whereas a negative one was observed with testosterone in adult males. 469

The exact mechanisms through which the steroid hormones alter the vaccination 470 response are still being explored. One interesting theory that has been suggested, 471 regarding the role of testosterone in attenuating the immune response, has focused on 472 the upregulation of a certain complex of genes. These genes are involved in lipid 473 biosynthesis and have been independently associated with poorer vaccination 474 outcomes in males but not in females. They also seem to exert anti-inflammatory 475 actions and appear to be expressed at higher levels in males [80] . As far as SARS-CoV-2 vaccination is concerned, a study measuring BNT162b2 494 mRNA vaccine's efficacy by comparing antibody production among different age 495 groups and sexes displayed similar results. In particular, women produced higher 496 antibody titers than men in all age groups and interestingly, this sex-specific 497 difference was substantially pronounced in the age group of 80-89 years. In both 498 sexes, an age-dependent antibody production was noted, as younger participants 499 exhibited not only a greater number of antibodies but also a more rapid response to 500 the vaccine [82] . 501

However, this ability of better antibody production could also act as a liability due to 502 the higher occurrence of adverse reactions in females. Besides, it is well established 503 that this immoderate immune reactivity is to blame for the prevailing incidence of Furthermore, it is known that women tend to have a better response to vaccines 554 against many viral agents. As COVID-19 immunization continues, the higher 555 percentages of adverse reactions in women pose the question whether this is also the 556 case for SARS-CoV-2. This increased frequency of side effects is possibly caused by 557 an augmented immune activation post injection. Nonetheless, more research is needed 558 to investigate the reasons behind this sex-specific vulnerability and to explore whether 559 the vaccine dosage should be readjusted to better fit the female immune system 560 properties. 561

In any case, the fact that females exhibit heightened immune reactivity undoubtedly 562 plays an important role in the better disease outcomes regarding SARS-CoV-2 563 infection and the majority of the studies conducted on this topic concur that one of the 564 primary causative factors of this dimorphism is the female hormonal profile. More 565 specifically, estrogens safeguard women and strengthen their immune system, but been restricted due to anticipated risks (mainly of breast cancer). Even if a relative 568 protection against SARS-CoV-2 infection is proven, it is doubted whether they could 569 be eligible as a therapeutic agent. Similarly, given that patients with lower 570 testosterone levels appear to be less susceptible to infection, an alternative hormonal 571 intervention could be that of ADT. However, considering the anticipated side-effects 572 it is questionable whether ADT could be of clinical use as a shield against SARS-573

CoV-2. TMPRSS2 inhibition could also pose as a potential treatment approach. 574

Regarding the latter, ongoing clinical trials are already testing this hypothesis using 575 the TMPRSS2 inhibitor Camostat Mesylate as a means of restriction of viral entry and 576 therefore infectivity. This could be of extreme importance in lowering the 577 transmission rate in the community. Another inhibitor, currently under investigation, 578 that could also benefit critically ill COVID-19 patients through its action as a 579 TMPRSS2 inhibitor, is Alpha-1 antitrypsin, which protects the airway and reduces 580 lung inflammation. Nonetheless, more in-depth research is required in order for this 581 agent to be of clinical use. 582

Our literature review bears some limitations due to the recent character of the disease. 

SeXX matters in immunity

Prevention and therapy of COVID-19 via exogenous estrogen 639 treatment for both male and female patients

COVID-19) Dashboard n

COVID-19 -A vascular disease

Report of the WHO-China Joint Mission on Coronavirus Disease

Prevalence of 665 comorbidities and its effects in patients infected with SARS-CoV-2: a systematic 666 review and meta-analysis

Gender Differences in the Regulation of Blood Pressure

Sex differences in coronary heart disease 671 and stroke mortality: a global assessment of the effect of ageing between 1980 and 672 2010

Severe obesity, increasing age and male sex are independently associated with 676 worse in-hospital outcomes, and higher in-hospital mortality

Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 683 patients in China: A meta-analysis

Associations of type 1 and type 2 diabetes with COVID-19-related mortality in

England: a whole-population study

Hypertension and sex related differences in mortality of COVID-19 693 infection: A systematic review and Meta-analysis

Sex Hormones Regulate Innate Immune Cells and Promote

Impaired estrogen signaling underlies regulatory T cell loss-of-function in 700 the chronically inflamed intestine

Autoimmune Orchitis in Rats: Evidence for a Direct Role of Testosterone on

Regulatory T Cell Expansion

17β-Estradiol, a potential ally to alleviate SARS-CoV-2 infection

Considering 711

The gendered impact of coronavirus disease 714 (COVID-19): do estrogens play a role?

The evolution of greater humoral immunity in females 717 than males: implications for vaccine efficacy

Sex differences in severity and mortality from

COVID-19: are males more vulnerable?

Stronger inflammatory/cytotoxic T-cell response in women identified by microarray 724 analysis

Regulation of innate and adaptive immunity by the 726 female sex hormones oestradiol and progesterone

Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in 730 men compared with women

The discovery of how attributes contributing to SARS-CoV-2 mortality

Endothelial dysfunction in Coronavirus disease

COVID-19): Gender and age influences

Estrogen shields women from

COVID-19 complications by reducing ER stress

Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome 748

Coronavirus Infection

Understanding Estrogen Action during Menopause

Sex differences in SARS-CoV-2 infection rates and the potential link to prostate 754 cancer

Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in 757 differentiated airway epithelial cells

SARS-CoV-2 and the possible connection to ERs

A crucial role of 764 angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

Sex-related differences in 767 COVID-19 lethality

Clinical and 770 biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung 771 injury

Angiotensin-774 converting enzyme 2 protects from severe acute lung failure

Molecular mechanisms of sex bias 777 differences in COVID-19 mortality

SEX DISPARITIES IN COVID-19 SEVERITY AND OUTCOME: ARE MEN 781 WEAKER OR WOMEN STRONGER? Neuroendocrinology

COVID-19 and its implications for thrombosis and 784 anticoagulation

The 790 protective role of estrogen and estrogen receptors in cardiovascular disease and the 791 controversial use of estrogen therapy

Sex and hormonal influences on platelet sensitivity and 794 coagulation in the rat

Estrogen stimulates 797 arachidonoylethanolamide release from human endothelial cells and platelet 798 activation

Potential in the Framingham Offspring Study

Interplay between male testosterone levels and the risk for subsequent 816 invasive respiratory assistance among COVID-19 patients at hospital admission

Role of C-Reactive Protein at Sites of 819 Inflammation and Infection

TMPRSS2 822 and COVID-19: Serendipity or Opportunity for Intervention?

Contributes to Virus Spread and Immunopathology in the Airways of

Murine Models after Coronavirus Infection

Sex, androgens and regulation of pulmonary AR, TMPRSS2 and ACE2

17β-estradiol reduces SARS-CoV-2 infection in vitro

Androgen Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe 846 COVID-19 Symptoms in Men

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS

CoV-2: a population-based study (N = 4532)

COVID-19 and lung cancer: risks

Men and COVID-19: the aftermath

Who is wearing a mask? Gender-, age-, and location-related differences during the 867 COVID-19 pandemic

Internet Use, Risk Awareness, and 870 Demographic Characteristics Associated With Engagement in Preventive Behaviors 871 and Testing: Cross-Sectional Survey on COVID-19 in the United States

COVID-19 in Spain render men more vulnerable than women?

Attitude and Practice Toward COVID-19 Among 878 the Public in the Kingdom of Saudi Arabia: A Cross-Sectional Study

Systems analysis of sex differences reveals an immunosuppressive role for 893 testosterone in the response to influenza vaccination

Estrogen Preferentially 896 Promotes the Differentiation of CD11c + CD11b intermediate Dendritic Cells from

Age-and gender-dependent antibody responses against SARS-CoV-2 in 901 health workers and octogenarians after vaccination with the BNT162b2 mRNA 902 vaccine

First Month of COVID-19 Vaccine Safety Monitoring -United States, 904 benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots

Heparin-915 induced Thrombocytopenia: Pathophysiology, Diagnosis and Management

Side effect worry grows for AstraZeneca vaccine